Market Insights Health Pharmacies OTC Products

Digestive & Intestinal Remedies (Pharmacies) - Central Africa

Central Africa

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$42.64m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.34%, resulting in a market volume of US$45.58m by 2029.
In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
In relation to total population figures, per person revenues of US$0.44 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Central Africa is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Central Africa are shifting towards natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceutical options. This preference for natural remedies is driving the demand for herbal digestive and intestinal remedies in the region. Trends in the market include the increasing availability of over-the-counter digestive and intestinal remedies in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for these remedies. Additionally, there is a growing awareness of the importance of digestive health, leading to an increase in the consumption of these products. The market is also witnessing a rise in the popularity of probiotics and other supplements that promote gut health. Local special circumstances in Central Africa, such as a high prevalence of gastrointestinal diseases and limited access to healthcare facilities, contribute to the growth of the Digestive & Intestinal Remedies market. Gastrointestinal diseases are common in the region, and the availability of effective remedies in local pharmacies is crucial for managing these conditions. Limited access to healthcare facilities further emphasizes the importance of having readily available remedies in pharmacies. Underlying macroeconomic factors, such as population growth and increasing disposable incomes, also play a role in the development of the Digestive & Intestinal Remedies market in Central Africa. As the population continues to grow, the demand for healthcare products, including digestive and intestinal remedies, is expected to increase. Rising disposable incomes allow consumers to afford these products and invest in their health and well-being. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Central Africa is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the availability of over-the-counter products in pharmacies, and the high prevalence of gastrointestinal diseases in the region are driving the growth of the market. With population growth and increasing disposable incomes, the demand for these remedies is expected to continue to rise in the future.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.